ID   CTL1_RAT                Reviewed;         656 AA.
AC   Q8VII6; Q9JJZ7;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   24-JUL-2024, entry version 116.
DE   RecName: Full=Choline transporter-like protein 1;
DE   AltName: Full=Solute carrier family 44 member 1;
DE   AltName: CD_antigen=CD92;
GN   Name=Slc44a1; Synonyms=Cd92, Cdw92, Ctl1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10677542; DOI=10.1073/pnas.030339697;
RA   O'Regan S., Traiffort E., Ruat M., Cha N., Compaore D., Meunier F.-M.;
RT   "An electric lobe suppressor for a yeast choline transport mutation belongs
RT   to a new family of transporter-like proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:1835-1840(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=15715662; DOI=10.1111/j.1471-4159.2004.02962.x;
RA   Traiffort E., Ruat M., O'Regan S., Meunier F.-M.;
RT   "Molecular characterization of the family of choline transporter-like
RT   proteins and their splice variants.";
RL   J. Neurochem. 92:1116-1125(2005).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-14; 57-71; 75-88; 90-104; 108-118; 161-174; 186-211;
RP   271-286; 421-433; 516-527; 620-629; 631-644 AND 646-656, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [4]
RP   INDUCTION.
RX   PubMed=12007839; DOI=10.1016/s0169-328x(02)00182-1;
RA   Che Y.H., Yamashita T., Higuchi H., Tohyama M.;
RT   "Changes in mRNA for choline transporter-like protein following facial
RT   nerve transection.";
RL   Brain Res. Mol. Brain Res. 101:122-125(2002).
RN   [5]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16000150; DOI=10.1111/j.1471-4159.2005.03299.x;
RA   Inazu M., Takeda H., Matsumiya T.;
RT   "Molecular and functional characterization of an Na-independent choline
RT   transporter in rat astrocytes.";
RL   J. Neurochem. 94:1427-1437(2005).
RN   [6]
RP   INDUCTION.
RX   PubMed=15691711; DOI=10.1016/j.mcn.2004.09.014;
RA   Lecomte M.-J., De Gois S., Guerci A., Ravassard P., Faucon Biguet N.,
RA   Mallet J., Berrard S.;
RT   "Differential expression and regulation of the high-affinity choline
RT   transporter CHT1 and choline acetyltransferase in neurons of superior
RT   cervical ganglia.";
RL   Mol. Cell. Neurosci. 28:303-313(2005).
RN   [7]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=19236841; DOI=10.1016/j.abb.2009.02.007;
RA   Yabuki M., Inazu M., Yamada T., Tajima H., Matsumiya T.;
RT   "Molecular and functional characterization of choline transporter in rat
RT   renal tubule epithelial NRK-52E cells.";
RL   Arch. Biochem. Biophys. 485:88-96(2009).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-134 AND ASN-179, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24090084; DOI=10.1021/pr400783j;
RA   Parker B.L., Thaysen-Andersen M., Solis N., Scott N.E., Larsen M.R.,
RA   Graham M.E., Packer N.H., Cordwell S.J.;
RT   "Site-specific glycan-peptide analysis for determination of N-glycoproteome
RT   heterogeneity.";
RL   J. Proteome Res. 12:5791-5800(2013).
CC   -!- FUNCTION: Choline transporter, acts as a choline/H+ antiporter
CC       (PubMed:19236841). Also acts as a high-affinity ethanolamine/H+
CC       antiporter, regulating the supply of extracellular ethanolamine (Etn)
CC       for the CDP-Etn pathway, redistribute intracellular Etn and balance the
CC       CDP-Cho and CDP-Etn arms of the Kennedy pathway (PubMed:19236841).
CC       Involved in membrane synthesis and myelin production (By similarity).
CC       {ECO:0000250|UniProtKB:Q8WWI5, ECO:0000269|PubMed:19236841}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=choline(out) + n H(+)(in) = choline(in) + n H(+)(out);
CC         Xref=Rhea:RHEA:75463, ChEBI:CHEBI:15354, ChEBI:CHEBI:15378;
CC         Evidence={ECO:0000269|PubMed:19236841};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ethanolamine(out) + n H(+)(in) = ethanolamine(in) + n
CC         H(+)(out); Xref=Rhea:RHEA:75467, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57603; Evidence={ECO:0000250|UniProtKB:Q8WWI5};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19236841};
CC       Multi-pass membrane protein {ECO:0000255}. Mitochondrion outer membrane
CC       {ECO:0000269|PubMed:19236841}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=CTL1a;
CC         IsoId=Q8VII6-1; Sequence=Displayed;
CC       Name=2; Synonyms=CTL1b;
CC         IsoId=Q8VII6-2; Sequence=VSP_015429, VSP_015430;
CC   -!- TISSUE SPECIFICITY: Expressed in neurons, oligodendrocytes and
CC       astrocytes. Also expressed in the mucosal cell layer of the colon. In
CC       the developing brain, isoform 1 is expressed in both neurons and
CC       oligodendroglial cells, whereas isoform 2 is restricted to
CC       oligodendroglial cells. {ECO:0000269|PubMed:10677542,
CC       ECO:0000269|PubMed:15715662, ECO:0000269|PubMed:16000150}.
CC   -!- INDUCTION: By leukemia inhibitory factor or retinoic acid in vitro. In
CC       vivo, induced during the axonal elongation period following axotomy.
CC       {ECO:0000269|PubMed:12007839, ECO:0000269|PubMed:15691711}.
CC   -!- SIMILARITY: Belongs to the CTL (choline transporter-like) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ245619; CAB75555.1; -; mRNA.
DR   EMBL; AJ420809; CAD12728.1; -; mRNA.
DR   RefSeq; NP_001029024.1; NM_001033852.1.
DR   RefSeq; NP_445944.2; NM_053492.3.
DR   AlphaFoldDB; Q8VII6; -.
DR   SMR; Q8VII6; -.
DR   STRING; 10116.ENSRNOP00000071535; -.
DR   GlyCosmos; Q8VII6; 2 sites, 6 glycans.
DR   GlyGen; Q8VII6; 2 sites, 6 N-linked glycans (2 sites).
DR   iPTMnet; Q8VII6; -.
DR   PhosphoSitePlus; Q8VII6; -.
DR   SwissPalm; Q8VII6; -.
DR   jPOST; Q8VII6; -.
DR   PaxDb; 10116-ENSRNOP00000024229; -.
DR   GeneID; 85254; -.
DR   KEGG; rno:85254; -.
DR   UCSC; RGD:621426; rat. [Q8VII6-1]
DR   AGR; RGD:621426; -.
DR   CTD; 23446; -.
DR   RGD; 621426; Slc44a1.
DR   eggNOG; KOG1362; Eukaryota.
DR   InParanoid; Q8VII6; -.
DR   OrthoDB; 551961at2759; -.
DR   PhylomeDB; Q8VII6; -.
DR   Reactome; R-RNO-1483191; Synthesis of PC.
DR   Reactome; R-RNO-425366; Transport of bile salts and organic acids, metal ions and amine compounds.
DR   Reactome; R-RNO-6798163; Choline catabolism.
DR   PRO; PR:Q8VII6; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0015297; F:antiporter activity; IEA:UniProtKB-KW.
DR   GO; GO:0015220; F:choline transmembrane transporter activity; IMP:ARUK-UCL.
DR   GO; GO:0034228; F:ethanolamine transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015871; P:choline transport; IMP:ARUK-UCL.
DR   GO; GO:0034229; P:ethanolamine transport; ISS:UniProtKB.
DR   GO; GO:0055085; P:transmembrane transport; IMP:ARUK-UCL.
DR   InterPro; IPR007603; Choline_transptr-like.
DR   PANTHER; PTHR12385; CHOLINE TRANSPORTER-LIKE (SLC FAMILY 44); 1.
DR   PANTHER; PTHR12385:SF56; CHOLINE TRANSPORTER-LIKE PROTEIN 1; 1.
DR   Pfam; PF04515; Choline_transpo; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Antiport; Cell membrane; Direct protein sequencing;
KW   Glycoprotein; Lipoprotein; Membrane; Mitochondrion;
KW   Mitochondrion outer membrane; Myristate; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT   CHAIN           2..656
FT                   /note="Choline transporter-like protein 1"
FT                   /id="PRO_0000191714"
FT   TOPO_DOM        2..29
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        30..50
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        51..211
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        212..232
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        233..237
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        238..258
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        259..287
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        288..308
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        309..314
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        315..335
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        336..337
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        338..358
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        359..379
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        380..400
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        401..441
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        442..462
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        463..536
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        537..557
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        558..565
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        566..586
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        587..656
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          635..656
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         651
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8WWI5"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        134
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   CARBOHYD        179
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   VAR_SEQ         650..653
FT                   /note="ASGA -> LRKR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10677542"
FT                   /id="VSP_015429"
FT   VAR_SEQ         654..656
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10677542"
FT                   /id="VSP_015430"
FT   CONFLICT        267
FT                   /note="R -> S (in Ref. 1; CAB75555)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        645
FT                   /note="K -> E (in Ref. 1; CAB75555)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   656 AA;  73092 MW;  217AAD02F6E4D138 CRC64;
     MGCCSSASAA QSSKREWKPL EDRSCTDIPW LLLFVLFCIG MGFICGFSVA TGAAARLVSG
     YDSYGNICGQ RNAKLEAIAN SGLDHTHRKY VFFLDPCNLD LINRKIKSMA LCVAACPRQE
     LKTLSDVQKF AEINGSALCS YNIKPSEYTL TAKSSAFCPK LPVPASAPIP FFHRCAPVNI
     SCYAKFAEAL ITFVSDNSVL HRLISGVMTS KEIILGLCLL SLVLSMILMV IIRYISRVLV
     WILTILVILG SLGGTGVLWW LYAKQRRSPK ETVIPEQLQI AEDNLRALLI YAISATVFTV
     ILFLIMLVMR KRVALTIALF HVAGKVFIHL PLLVFQPFWT FFALVLFWAY WIMTLLFLGT
     TGSAVQNEQG FVEYKISGPL QYMWWYHVVG LIWISEFILA CQQMTVAGAV VTYYFTRDKR
     NLPFTPILAS VNRLIRYHLG TVAKGSFIIT LVKIPRMILM YIHSQLKGKE NACARCMLKS
     CICCLWCLEK CLSYLNQNAY TATAINSTNF CTSAKDAFVI LVENALRVAA INTVGDFMLF
     LGKVLIVCST GLAGIMLLNY QQDYTVWVLP LIIVCLFAFL VAHCFLSIYE MVVDVLFLCF
     AIDTKYNDGS PGREFYMDKV LMEFVENSRK AMKEAGKGGA ADARKLKPMA SGASSA
//
